Better referred to as ALS or Lou Gehrigs disease.

The work was carried out by a team of researchers from the University of Rochester Medical Center, led neuroscientist Berislav Zloikovic, MD, PhD; The Scripps Study Institute in La Jolla, including John Griffin, PhD, an expert on the APC enzyme; the University of Notre Dame; and a Rochester-based start-up biotech company, Socratech. Initial authors of the paper were Zhihui Zhong of Rochester and post-doctoral associate Hristelina Ilieva with the Ludwig Institute at UC San Diego. The experts studied mice with a mutation in a gene called superoxide dismutase 1 , which has an important part in keeping cells safe from damaging molecules referred to as free radicals. While the cause of most situations of ALS is unknown, scientists can say for certain that SOD1 is important in approximately three to four % of situations – providing an opportunity to study the disease’s initial steps, which occur long before key nerve cells appear sick or die.Copyright 2009 Advisory Board Organization and Kaiser Family Base. All rights reserved.

2 bills to expand mental coverage of health introduced Two bills to expand mental coverage of health were introduced Thursday. National Journal: Senators Introduce Costs To Expand Medicare Mental Health Coverage In a bipartisan effort to provide equality to mental illness coverage for Medicare beneficiaries, Sens. John Kerry, D-Mass., and Olympia Snowe, R-Maine, introduced a expenses eliminating psychiatric treatment caps. Under current Medicare regulations, beneficiaries are offered up to 190 days of inpatient psychiatric treatment in a hospital through the duration of the policy.